{"product_id":"infectious-disease-surveillance-isbn-9780470654675","title":"Infectious Disease Surveillance","description":"\u003cp\u003eThis fully updated edition of \u003ci\u003eInfectious Disease Surveillance\u003c\/i\u003e is for frontline public health practitioners, epidemiologists, and clinical microbiologists who are engaged in communicable disease control. It is also a foundational text for trainees in public health, applied epidemiology, postgraduate medicine and nursing programs. \u003c\/p\u003e \u003cp\u003eThe second edition portrays both the conceptual framework and practical aspects of infectious disease surveillance. It is a comprehensive resource designed to improve the tracking of infectious diseases and to serve as a starting point in the development of new surveillance systems. \u003ci\u003eInfectious Disease Surveillance\u003c\/i\u003e includes over 45 chapters from over 100 contributors, and topics organized into six sections based on major themes.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection One\u003c\/b\u003e highlights the critical role surveillance plays in public health and it provides an overview of the current International Health Regulations (2005) in addition to successes and challenges in infectious disease eradication. \u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection Two\u003c\/b\u003e describes surveillance systems based on logical program areas such as foodborne illnesses, vector-borne diseases, sexually transmitted diseases, viral hepatitis healthcare and transplantation associated infections. Attention is devoted to programs for monitoring unexplained deaths, agents of bioterrorism, mass gatherings, and disease associated with international travel.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSections Three and Four\u003c\/b\u003e explore the uses of the Internet and wireless technologies to advance infectious disease surveillance in various settings with emphasis on best practices based on deployed systems. They also address molecular laboratory methods, and statistical and geospatial analysis, and evaluation of systems for early epidemic detection.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSections Five and Six\u003c\/b\u003e discuss legal and ethical considerations, communication strategies and applied epidemiology-training programs. The rest of the chapters offer public-private partnerships, as well lessons from the 2009-2010 H1N1 influenza pandemic and future directions for infectious disease surveillance.\u003c\/p\u003e  \u003cp\u003e\u003ci\u003eContributors x\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eForeword to the Second Edition xix\u003cbr\u003e \u003ci\u003eStephen B. Thacker \u0026amp; Denis M. Coulombier\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eForeword to the First Edition xxi\u003cbr\u003e \u003ci\u003eAnne Schuchat \u0026amp; Jean-Claude Desenclos\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePreface to Second Edition xxiii\u003cbr\u003e \u003ci\u003eNkuchia M. M’ikanatha, Ruth Lynfield, Chris A. Van Beneden, \u0026amp; Henriette de Valk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003ePreface to First Edition xxv\u003cbr\u003e \u003ci\u003eNkuchia M. M’ikanatha, Ruth Lynfield, Chris Van Beneden, \u0026amp; Henriette de Valk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eAcknowledgments xxvii\u003c\/p\u003e \u003cp\u003eWeighing of the Heart xxviii\u003cbr\u003e \u003ci\u003ePolyxeni Potter\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 1: Introduction to Infectious Disease Surveillance\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Infectious Disease Surveillance: A Cornerstone for Prevention and Control 3\u003cbr\u003e \u003ci\u003eNkuchia M. M’ikanatha, Ruth Lynfield, Kathleen G. Julian, Chris A. Van Beneden, \u0026amp; Henriette de Valk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Origins and Progress in Surveillance Systems 21\u003cbr\u003e \u003ci\u003eStephen B. Thacker \u0026amp; Donna F. Stroup\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Use of Surveillance in Disease Eradication Efforts 32\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1: Introduction to the Concept and Use of Surveillance in the Eradication of Smallpox 32\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eD.A. Henderson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2: Lessons Learned in Guinea Worm Disease (Dracunculiasis) Eradication 41\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eSamuel Makoy, Steven R. Becknell, Alexander H. Jones, Gabriel Waat, Ernesto Ruiz-tiben, \u0026amp; Donald R. Hopkins\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3: Surveillance for Measles Eradication in Countries with Limited Resources 54\u003c\/b\u003e\u003cbr\u003e Mark Grabowsky, Mac Otten, \u0026amp; Balcha Masresha\u003c\/p\u003e \u003cp\u003e4 Infectious Disease Surveillance and the International Health Regulations 62\u003cbr\u003e \u003ci\u003eBruce J. Plotkin \u0026amp; Maxwell C. Hardiman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Supranational Surveillance in the European Union 81\u003cbr\u003e \u003ci\u003eAndrea Ammon \u0026amp; Edward van Straten\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 2: Program Area Surveillance Systems\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e6 Active, Population-based Surveillance for Infectious Diseases 95\u003cbr\u003e \u003ci\u003eChris A. Van Beneden, Melissa Arvay, Somsak Thamthitiwat, \u0026amp; Ruth Lynfield\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Surveillance for Foodborne Diseases 109\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1: Approaches to Surveillance for Foodborne Diseases 109\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eElaine Scallan, Barbara Mahon, \u0026amp; Danilo Lo Fo Wong\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2: Investigation of Foodborne Disease Outbreaks 120\u003c\/b\u003e\u003cbr\u003e Stephanie D. Meyer, Kirk E. Smith, \u0026amp; Craig Hedberg\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3: Surveillance for Antimicrobial Resistance Among Foodborne Bacteria—the US Approach 129\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eJean M. Whichard, Kathryn Gay, Heather Tate, \u0026amp; Tom M. Chiller\u003c\/i\u003e\u003cbr\u003e \u003cbr\u003e 8 Surveillance for Zoonotic Diseases 143\u003cbr\u003e \u003ci\u003eMira J. Leslie \u0026amp; James J. Kazmierczak\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Surveillance for Vector-borne Diseases 157\u003cbr\u003e \u003ci\u003eLyle R. Petersen \u0026amp; James L. Hadler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Surveillance for Vaccine-preventable Diseases 174\u003cbr\u003e \u003ci\u003eHanna M. Nohynek \u0026amp; Elizabeth Miller\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Public Health Surveillance for Vaccine Adverse Events 187\u003cbr\u003e \u003ci\u003eJohn K. Iskander \u0026amp; Yenlik Zheteyeva\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Seasonal and Pandemic Influenza Surveillance 200\u003cbr\u003e \u003ci\u003eLynnette Brammer, Alicia P. Budd, \u0026amp; Lyn Finelli\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Surveillance for Agents of Bioterrorism in the USA 211\u003cbr\u003e \u003ci\u003eRichard N. Danila \u0026amp; Aaron T. Fleischauer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Surveillance for Unexplained Infectious Disease-related Deaths 223\u003cbr\u003e \u003ci\u003eRuth Lynfield, Kurt B. Nolte, Ann M. Schmitz, \u0026amp; Marc Fischer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Surveillance for Tuberculosis 234\u003cbr\u003e \u003ci\u003eDelphine Antoine \u0026amp; Ibrahim Abubakar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Surveillance for Healthcare-associated Infections 248\u003cbr\u003e \u003ci\u003ePetra Gastmeier, Bruno Coignard, \u0026amp; Teresa C. Horan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Biovigilance: Designing and Implementing Surveillance Systems for the Safety and Quality of Blood, Organs, and Tissues 261\u003cbr\u003e \u003ci\u003eMatthew J. Kuehnert, Robert P. Wise, \u0026amp; Jerry A. Holmberg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Surveillance for Antimicrobial Resistance and Trends in Antimicrobial Utilization 274\u003cbr\u003e \u003ci\u003eKatherine Fleming-Dutra, Lauri A. Hicks, \u0026amp; Hajo Grundmann\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Surveillance for Viral Hepatitis in Europe 288\u003cbr\u003e \u003ci\u003eMary E. Ramsay, Koye Balogun, Catherine Quigley, \u0026amp; Chee Fu Yung\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Surveillance for Human Immunodeficiency Virus Infection in the USA 304\u003cbr\u003e \u003ci\u003eEve D. Mokotoff \u0026amp; R. Luke Shouse\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Surveillance for Human Immunodeficiency Virus\/Acquired Immunodeficiency Syndrome for Countries in Transition 317\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1: Surveillance for Human Immunodeficiency Virus\/Acquired Immunodeficiency Syndrome in India 317\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eRubina Imtiaz, Renu Garg, \u0026amp; Madhulekha Bhattacharya\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2: Surveillance for Human Immunodeficiency Virus\/Acquired Immunodeficiency Syndrome in Russia 327\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eDmitry M. Kissin, Charles R. Vitek, Evgeny Voronin, \u0026amp; Susan D. Hillis\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3: Surveillance for Human Immunodeficiency Virus\/Acquired Immunodeficiency Syndrome in South Africa 334\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eThomas M. Rehle \u0026amp; Gita Ramjee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Surveillance for Sexually Transmitted Diseases 343\u003cbr\u003e \u003ci\u003eSamuel L. Groseclose, Michael C. Samuel, Joan M. Chow, \u0026amp; Hillard Weinstock\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Communicable Disease Surveillance During Complex Emergencies 361\u003cbr\u003e \u003ci\u003eMarta Valenciano, Francisco J. Luquero, \u0026amp; Alain Moren\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Infectious Disease Surveillance in Globally Mobile Populations 376\u003cbr\u003e \u003ci\u003eKatrin S. Kohl \u0026amp; Alfonso Rodriguez-Lainz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Surveillance for Infectious Diseases in Mass Gatherings 388\u003cbr\u003e \u003ci\u003eAndrea M. Forde\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 3: Internet- and Wireless-based Information Systems in Infectious Disease Surveillance\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e26 Use of the Web to Enhance Infectious Disease Surveillance 403\u003cbr\u003e \u003ci\u003eNkuchia M. M’ikanatha, Dale D. Rohn, Toby McAdams, David P. Welliver, \u0026amp; Kathleen G. Julian\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Web-based Sentinel Provider Surveillance Network in France 418\u003cbr\u003e \u003ci\u003eThierry Blanchon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 Electronic Surveillance for Infectious Diseases in Germany 426\u003cbr\u003e \u003ci\u003eG´erard Krause\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29 Electronic Clinical Laboratory Reporting for Public Health Surveillance 434\u003cbr\u003e \u003ci\u003ePerry F. Smith, Guthrie S. Birkhead, \u0026amp; J.A. Magnuson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Mobile Technology for Infectious Disease Surveillance 447\u003cbr\u003e \u003ci\u003eHerman D. Tolentino, John S. Brownstein, Barbara L. Massoudi, \u0026amp; Mehran S. Massoudi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e31 The Global Public Health Intelligence Network 457\u003cbr\u003e \u003ci\u003eAbla Mawudeku, Michael Blench, Louise Boily, Ron St. John, Roberta Andraghetti, \u0026amp; Martha Ruben\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32 Syndromic Surveillance for Infectious Diseases 470\u003cbr\u003e \u003ci\u003eJulie A. Pavlin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 4: Molecular Methods, Data Analyses, and Evaluation of Surveillance Systems\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e33 Use of Molecular Epidemiology in Infectious Disease Surveillance 485\u003cbr\u003e \u003ci\u003eJohn M. Besser\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Software Applications, Resources, and Introduction to Statistical Analysis 502\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1: Examples of Software Application and Web-based Resources for Infectious Disease Surveillance 502\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eJohn H. Holmes, Michael C. Samuel, Gilles Desv´e, \u0026amp; Joseph M. Hilbe\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2: Analysis and Interpretation of Reportable Infectious Disease Data 508\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eMindy J. Perilla \u0026amp; Elizabeth R. Zell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 Analysis and Interpretation of Case-based Infectious Disease Surveillance Data: Human Immunodeficiency Virus-related Morbidity and Mortality Surveillance in the USA 522\u003cbr\u003e \u003ci\u003eLisa M. Lee \u0026amp; George W. Rutherford\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 Statistical Modeling of Infectious Disease Surveillance Data 535\u003cbr\u003e \u003ci\u003eLeonhard Held \u0026amp; Michaela Paul\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37 Geospatial Technologies and Spatial Data Analysis 545\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1: Geographic Information System Approaches to Data Analysis 545\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eChester G. Moore \u0026amp; Jerome E. Freier\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2: Use of Geographic Information Systems and Spatial Analysis in Infectious Disease Surveillance in North America and East Africa 558\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eSunny Mak \u0026amp; Rebecca J. Eisen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e38 Evaluation of Syndromic Surveillance Systems that Use Healthcare Data 565\u003cbr\u003e \u003ci\u003eSamuel L. Groseclose, David L. Buckeridge, \u0026amp; James W. Buehler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 5: Basic Considerations, Communications, and Training in Infectious Disease Surveillance\u003c\/b\u003e\u003cbr\u003e \u003cbr\u003e 39 Legal Basis for Infectious Disease Surveillance and Control in the USA 583\u003cbr\u003e \u003ci\u003eRichard E. Hoffman \u0026amp; Frederic E. Shaw\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e40 Ethics and Public Health Surveillance 596\u003cbr\u003e \u003ci\u003eAmy L. Fairchild \u0026amp; David M. Johns\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e41 Communication in Infectious Disease Surveillance 607\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1: Communication, Mass Media Relations, and Infectious Disease Surveillance 607\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eBrian G. Southwell, Barbara J. Reynolds, \u0026amp; Kate Fowlie\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2: Health Communication Case Study 618\u003c\/b\u003e\u003cbr\u003e \u003ci\u003eJeffrey D. Klausner \u0026amp; Katherine Ahrens\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42 Training in Infectious Disease Surveillance: Contributions of the Epidemic Intelligence Service and European Field Epidemiology Training Programs 623\u003cbr\u003e \u003ci\u003eDenise Koo, Douglas H. Hamilton, \u0026amp; Arnold Bosman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e43 Surveillance Training for Fogarty International Fellows from Eastern Europe and Central Asia: the New York State Experience 636\u003cbr\u003e \u003ci\u003eDale L. Morse, Robert A. Bednarczyk, \u0026amp; Louise-Anne McNutt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 6: Partnerships, Policy, and Preparedness\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e44 Public–Private Partnerships in Infectious Disease Surveillance 649\u003cbr\u003e \u003ci\u003eAndrew Friede\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e45 2009 Pandemic Influenza A (H1N1) Surveillance in the USA 657\u003cbr\u003e \u003ci\u003eMichael A. Jhung, Lynnette Brammer, \u0026amp; Lyn Finelli\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e46 Future Directions in Infectious Disease Surveillance 668\u003cbr\u003e \u003ci\u003eRuth Lynfield, Nkuchia M. M’ikanatha, Chris A. Van Beneden, \u0026amp; Henriette de Valk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003ci\u003eIndex 671\u003c\/i\u003e\u003c\/p\u003e  \u003cp\u003e“This is a clear and understandable reference for creating and assessing infectious disease surveillance systems. It is a useful revision to the previous edition and is an excellent book for any public health or epidemiology classroom. ”  (\u003ci\u003eDoody’s\u003c\/i\u003e, 30 August 2013)\u003c\/p\u003e  \u003cp\u003e\u003cb\u003eNkuchia M. M’ikanatha\u003c\/b\u003e, Division of Infectious Disease Epidemiology, Pennsylvania Department of Health, Harrisburg, PA, USA\u003cbr\u003e \u003cb\u003eRuth Lynfield\u003c\/b\u003e, Minnesota Department of Health, St Paul, MN, USA\u003cbr\u003e \u003cb\u003eChris A. Van Beneden\u003c\/b\u003e, Respiratory Diseases Branch, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA\u003cbr\u003e \u003cb\u003eHenriette de Valk\u003c\/b\u003e, Infectious Disease Department, Institut de Veille Sanitaire, Saint Maurice, France\u003c\/p\u003e  \u003cp\u003eThis fully updated edition of \u003ci\u003eInfectious Disease Surveillance\u003c\/i\u003e is for frontline public health practitioners, epidemiologists, and clinical microbiologists who are engaged in communicable disease control. It is also a foundational text for trainees in public health, applied epidemiology, postgraduate medicine and nursing programs. \u003c\/p\u003e \u003cp\u003eThe second edition portrays both the conceptual framework and practical aspects of infectious disease surveillance. It is a comprehensive resource designed to improve the tracking of infectious diseases and to serve as a starting point in the development of new surveillance systems. \u003ci\u003eInfectious Disease Surveillance\u003c\/i\u003e includes over 45 chapters from over 100 contributors, and topics organized into six sections based on major themes.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection One\u003c\/b\u003e highlights the critical role surveillance plays in public health and it provides an overview of the current International Health Regulations (2005) in addition to successes and challenges in infectious disease eradication. \u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection Two\u003c\/b\u003e describes surveillance systems based on logical program areas such as foodborne illnesses, vector-borne diseases, sexually transmitted diseases, viral hepatitis healthcare and transplantation associated infections. Attention is devoted to programs for monitoring unexplained deaths, agents of bioterrorism, mass gatherings, and disease associated with international travel.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSections Three and Four\u003c\/b\u003e explore the uses of the Internet and wireless technologies to advance infectious disease surveillance in various settings with emphasis on best practices based on deployed systems. They also address molecular laboratory methods, and statistical and geospatial analysis, and evaluation of systems for early epidemic detection.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSections Five and Six\u003c\/b\u003e discuss legal and ethical considerations, communication strategies and applied epidemiology-training programs. The rest of the chapters offer public-private partnerships, as well lessons from the 2009-2010 H1N1 influenza pandemic and future directions for infectious disease surveillance.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989419671781,"sku":"NP9780470654675","price":182.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9780470654675.jpg?v=1761784033","url":"https:\/\/k12savings.com\/es\/products\/infectious-disease-surveillance-isbn-9780470654675","provider":"K12savings","version":"1.0","type":"link"}